137 related articles for article (PubMed ID: 27551476)
1. Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors.
Menachem A; Bodner O; Pastor J; Raz A; Kloog Y
Cell Death Discov; 2015; 1():15047. PubMed ID: 27551476
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
Levy R; Grafi-Cohen M; Kraiem Z; Kloog Y
Mol Cancer Ther; 2010 Aug; 9(8):2208-19. PubMed ID: 20682656
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
[TBL] [Abstract][Full Text] [Related]
4. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.
Jiang C; Song T; Li J; Ao F; Gong X; Lu Y; Zhang C; Chen L; Liu Y; He H; Huang O
Mol Neurobiol; 2017 Jan; 54(1):779-787. PubMed ID: 27021020
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
Biran A; Brownstein M; Haklai R; Kloog Y
Int J Cancer; 2011 Feb; 128(3):691-701. PubMed ID: 20473860
[TBL] [Abstract][Full Text] [Related]
6. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y
Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression.
Chatterjee S; Rhee Y; Chung PS; Ge RF; Ahn JC
J Photochem Photobiol B; 2018 Feb; 179():46-53. PubMed ID: 29331658
[TBL] [Abstract][Full Text] [Related]
9. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.
Mitsiades CS; McMillin D; Kotoula V; Poulaki V; McMullan C; Negri J; Fanourakis G; Tseleni-Balafouta S; Ain KB; Mitsiades N
J Clin Endocrinol Metab; 2006 Oct; 91(10):4013-21. PubMed ID: 16849420
[TBL] [Abstract][Full Text] [Related]
11. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
12. Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.
Abu-Elsaad NM; Elkashef WF
Can J Physiol Pharmacol; 2016 May; 94(5):554-62. PubMed ID: 27010252
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
Egozi Y; Weisz B; Gana-Weisz M; Ben-Baruch G; Kloog Y
Int J Cancer; 1999 Mar; 80(6):911-8. PubMed ID: 10074926
[TBL] [Abstract][Full Text] [Related]
14. Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
Makovski V; Haklai R; Kloog Y
Int J Cancer; 2012 Mar; 130(6):1420-9. PubMed ID: 21500191
[TBL] [Abstract][Full Text] [Related]
15. Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells.
Beiner ME; Niv H; Haklai R; Elad-Sfadia G; Kloog Y; Ben-Baruch G
Int J Gynecol Cancer; 2006; 16 Suppl 1():200-6. PubMed ID: 16515591
[TBL] [Abstract][Full Text] [Related]
16. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes].
Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175
[TBL] [Abstract][Full Text] [Related]
17. Generation of self-clusters of galectin-1 in the farnesyl-bound form.
Yamaguchi K; Niwa Y; Nakabayashi T; Hiramatsu H
Sci Rep; 2016 Sep; 6():32999. PubMed ID: 27624845
[TBL] [Abstract][Full Text] [Related]
18. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.
Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
J Pathol; 2009 May; 218(1):66-75. PubMed ID: 19199318
[TBL] [Abstract][Full Text] [Related]
19. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
[TBL] [Abstract][Full Text] [Related]
20. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.
Lam KY; Lo CY; Chan KW; Wan KY
Ann Surg; 2000 Mar; 231(3):329-38. PubMed ID: 10714625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
